Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients With Newly Diagnosed Glioblastoma
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Jun 2018
At a glance
- Drugs Poly ICLC (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- 31 May 2018 Status changed from recruiting to active, no longer recruiting.
- 09 Nov 2017 Status changed from not yet recruiting to recruiting.
- 21 Jul 2017 New trial record